Fernández Lago, C., & Castro Casal, M. (2011). Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response.
Citación estilo ChicagoFernández Lago, Carlos, y Margarita Castro Casal. Darbepoetin Alfa for Anemia in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes and Positive Predictive Factors of Response. 2011.
Cita MLAFernández Lago, Carlos, y Margarita Castro Casal. Darbepoetin Alfa for Anemia in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes and Positive Predictive Factors of Response. 2011.
Precaución: Estas citas no son 100% exactas.